Tom Says: youtube.com videos often come from sources more credible than (say) Fox News (Faux News/Fox Noise). Here are links from credible peer-reviewed medical science journals.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2510818

http://www.ncbi.nlm.nih.gov/pubmed/19031451

http://www3.interscience.wiley.com/cgi-bin/fulltext/121531612/PDFSTART

And note that 2.5 years later there is no follow-up by the NIAID, DAIDS, or ACTG. The conflicts of interest are enormous. HIV/AIDS is now a $20-30 Billion/year industry. Inexpensive cures for early infections are condemned by the people who run the NIAID, DAIDS & ACTG. “Money talks”, while cures “walk” (walk away completely ignored).

What Nobuto Yamamoto, Ph.D. et al proved is that HIV destroys the carrier molecule (GcMAF) for the hormone vitamin-D3. And that restoring that carrier molecule (GcMAF), early in someone’s HIV infection, allows their immune systems to clear HIV – before HIV shuts-down their immune systems and allows all the microbes we carry (CMV, HPV, etc) to destroy those immune systems.

i am following their results on blogs/forums it is more than 100 patients on trial, the bad side is those doctors don t accept other patients than cfs infected ones

cfs makes immune system impairment similar to aids and the severe cases with many viruses like cmv, ebv and others at high titers so it is very good to see how potent the treatment is although CFS is much more difficult to treat than a single virus infection like hiv, hbv or hcv

Yes, those profiting from “treatment” will invest deeply in preventing any severe loss of revenue, regardless of the human toll…however let’s hope in this specific battle of good and evil that good prevails. I enjoyed your comment, Nick!

I estimate that AZT (Retrovir/zodovudine) raked-in a minimum of $20 billion in profit (so far) for the four patent holders (pharmaceutical companies), dozens of drug wholesalers and tens of thousands of drug retailers. Not bad for a drug that was discovered and clinically tested almost totally by the American tax payer.

Two Japanese teams, led by Japanese-American Dr. Nobuto Yamamoto, have cured 39 young, healthy, recently HIV-infected Japanese patients, according to a January 2009 paper in the Journal of Clinical Virology, and according to FOCIS (immunology) meeting abstracts/posters from 2006, 2007, 2008 & 2009 AND according to a paper/poster presented at the 2010 International AIDS Conference, and according to a Russia Today TV interview with the author of the paper/poster Professor Marco Ruggiero.

http://www.youtube.com/watch?v=n4eMkdYhaZE

Although this is NOT a cure for AIDS, it is far more “suggestive” of a cure for (early) HIV infection than whole body radiation, chemo- therapy and rare donor-matched bone marrow transplant, BECAUSE 39 people have been cured – as opposed to just one (Timothy Ray Brown).

Timothy Ray Brown’s treatment cost many hundreds of thousands of dollars – perhaps close to a million dollars. The safer Japanese early treatment costs several thousand, perhaps close to ten thousand dollars.

The problem with the Japanese treatment (GcMAF, a.k.a. Dbp-MAF, a.k.a. Globulin (Gc) Allele) is that it is naturally made by all humans – like factor VIII for hemophilia. Therefore, it can NOT be patented. And although factor VIII is now made by genetically engineered organisms, GcMAF has no backers given that all the money is in treatment, not cures.

Dr. Nobuto Yamamoto has a patent on a truncated version of GcMAF. And his most recent (early 2010) FOCIS conference paper/abstract claims that, of the 24 recently HIV-infected patients cured, some of them were cured with the truncated (patented version) of GcMAF in as little as eight weeks. But, a full peer-reviewed paper has yet to be published on this patentable treatment. Note that Dr. Yamamoto is now 86 years old, and works out of his house.

No American clinical trials are being run on GcMAF – that can be found by GOOGLING the internet.

Worse, no American media organizations DARE to interview Dr. Yamamoto. Far worse, no American HIV/AIDS organizations DARE to interview him – even those working and living just a few miles from his home. Far, far, worse, American coverage of the 2010 International AIDS Conference purposefully ignored the announcement that Dr. Yamamoto had cured 39 young, healthy, recently-HIV-infected Japanese patients over the past 8.5 years. Yet, his (one) peer reviewed paper and (many) FOCIS (Immunology) conference papers/abstracts are on the internet – for free or a small fee.

Rumors have it that the NIAID is funding both Dr. Yamamoto’s and Professor Marco Ruggiero’s work with GcMAF. But, that work appears to be focused on cancer – as opposed to HIV.

In January 2010, the Southern University of Denmark published a paper in Biochimica et Biophysica Acta, titled ‘The glycosylation and characterization of the candidate Gc macrophage
activating factor’ indicating that they are working on GcMAF. Denmark is home to the world’s larest manufacturer of insulin. Like GcMAF, insulin must be injected. Novo Nordisk has the technology and know-how to make large amounts of GcMAF.

A company in Israel and a company in the Netherlands makes AND sells GcMAF. But, there does not appear to be any formal clinical studies of their GcMAF.

Only the teams of Dr. Nobuto Yamamoto have years of clinical follow-up on their 15+24=-39 ex-HIV patients using THEIR GcMAF treatments.

The world waits… for clinical trials from an 86 y/o man (Dr. Yamamoto) who now works from his home, while toxic and non-curing AZT rakes-in tens of billions of dollars.

Given that AZT was discovered and developed with nearly 100% public funding, I would hope that those who now lead our public fight against HIV would support a KNOWN CURE (GcMAF) with the same support that they once gave AZT.

But seriously, there aren’t enough HIV patients for HIV drugs to ever be anything more than a tiny, tiny drop in the bucket for Pharmaceuticals profit-wise.

These companies make their big bucks on statins and ACE inhibitors, and other drugs of this sort. Individually cheap medications that huge numbers of people over a certain age end up having indications for taking, for preventive rather than curative reasons necessitating continued usage for the remainder of their lives.

If/when they figure out how to manipulate our own tissues via gene therapy/stem cells to produce T-cells lacking the CCR5 receptor, I think that will change things dramatically. Wiping out one’s immune system and performing a risky bone marrow transplant will not be the only option, and I hope that alternative methods of therapy are created (and not halted by fundamentalist government like we have seen recently in US history) as this opening of the door towards a cure widens.

Now available translated from German to English for the first time, this book is a must-read for doctors, patients and anyone following the cutting edge of biology and immunology. With the blasting open of such doors of knowledge, the medical world will never again be the same.

“The knowledge this book conveys may revolutionize cancer and AIDS therapy in the coming years. After having read this book, no responsible doctor should continue to provide such harmful therapy to the patients in his/her care and trust. This book will inform them about the fatal mistakes of their previous therapies, of which until now they were the unwitting victims.”

“Additionally, this book is indispensable reading for the patient afflicted with cancer or AIDS. Herein for the first time, the exact reasons are revealed to the world why neither cancer nor AIDS must inevitably result in death. These two illnesses are the natural result of a systemic imbalance, which not only can be halted, but can also be healed.”

‘“The Catch-22 here is that the best candidates for a cure, ideally, are people who are healthy” and don’t have leukemia.’ Great! What percentage of HIV patients also have leukemia? Small percent? Too bad they don’t have conditions necessitating bone marrow transplants from HIV resistant donors.

The side effects from the treatment were pretty bad, but so are the side effects of the antiviral treatments currently used to fight HIV (liver failure and neuropathy being some of the more dire).

What will be much, much more interesting is when they figure out how to take the patients own bone marrow cells and use some gene therapy procedures to implant the necessary genes to express the cells in a way they are HIV resistant – we do have these techniques, however experimental, and hopefully they will converge. That should wipe out all the bone marrow matching issues. And the funny part is that neutered HIV viruses could be used for such gene therapies, as HIV is most adept at the one huge obstacle of gene therapy, namely getting genes into cells.

If we didn’t have modern medicine, HIV/AIDS would have wiped out quite a large portion of some of our societies. Those who are evolutionarily resistant, of course, would survive and breed and make the species stronger. However, thanks to our technology, we can just make everyone resistant and our whole species stronger without all that suffering and death and what-not.